Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT(1A) receptors in the rat brain

British Journal of Pharmacology

Volumn 123, Issue 3, 1998, Pages 449-462

  Corradetti, Renato ^b   Laaris, Nora ^a   Hanoun, Naima ^a   Laporte, Anne Marie ^a   Le Poul, Emmanuel ^a   Hamon, Michel ^a   Lanfumey, Laurence ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

( ) pindolol; 5 HT(1A) receptors; 5 hydroxytryptamine; Antidepressant; Dorsal raphe nucleus; Hippocampus; Hyperpolarization; In vivo occupancy

Indexed keywords

5 CARBAMOYLTRYPTAMINE; IPSAPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; SEROTONIN 1A RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; DORSAL RAPHE NUCLEUS; HIPPOCAMPUS; HYPERPOLARIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; RECEPTOR OCCUPANCY; SEROTONINERGIC NERVE CELL;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; PINDOLOL; PIPERAZINES; PYRIDINES; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN ANTAGONISTS; SYNAPSES;

EID: 0031965171     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701632     Document Type: Article

References (45)

1. 4-like-receptors mediate the slow excitatory response to serotonin in the rat hippocampus, J. Pharmacol. Exp. Ther., 257, 930-937.
2. B receptors to the same channels in hippocampus. Science, 234, 1261-1265.
3. ARTIGAS, F., PEREZ, V. & ALVAREZ, E. (1994). Pindolol induces a rapid improvement of patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry, 51, 248-251.
4. 1A antagonists. Trends Neurosci., 19, 378-383.
5. 1A receptor. Neurosci. Lett., 99, 101-106.
6. 1A-mediated hyperpolarization in CA1 and CA3 hippocampal pyramidal cells. J. Pharmacol. Exp. Ther., 263, 350-359.
7. BERMAN, R.M., DARNELL, A.M., MILLER, H.L. ANAND, A. & CHARNEY, D.S. (1997). Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am. J. Psychiatry, 154, 37-43.
8. BLIER, P. and BERGERON, R. (1995). Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol., 15, 217-222.
9. BLIER, P., DE MONTIGNY, C. & CHAPUT, Y. (1988). Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission. Clin. Neuropharmacol., 11, S1-S10.
10. CESANA, R., CIPRANDI, C. & BORSINI, F. (1995). The effect of BIMT 17, a new potential antidepressant, in the forced swimming test in mice. Behav. Pharmacol., 6, 688-694.
11. CHAPUT, Y., DE MONTIGNY, C. & BLIER, P. (1986). Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 333, 342-348.
12. CORRADETTI, R., LE POUL, E., LAARIS, N., HAMON, M. & LANFUMEY, L. (1996). Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. J. Pharmacol. Exp. Ther., 278, 679-688.
13. 1A agonists. Synapse, 14, 297-304.
14. DE MONTIGNY, C., BLIER, P. & CHAPUT, Y. (1990). Electrophysiological investigation of the effects of antidepressant treatments on serotonin receptors. In: Serotonin: From Cell Biology to Pharmacology and Therapeutics, ed. Vanhoutte, P.M., Paoletti, R., Brunello, N. & Maggi, F.M. pp. 499-504. Dordrecht: Kluwer Academic Publishers.
15. 1A receptor antagonists. Psychopharmacology, 119, 47-54.
16. 1A receptor antagonist. Behav. Brain Res., 73, 337-353.
17. 1A receptor antagonist. WAY-100635. Eur. J. Pharmacol., 281, 81-88.
18. FRAZER, A. & HENSLER, G.G. (1994). Serotonin. In: Basic Neurochemistry: Cellular and Molecular Aspects, ed. Siegel, G.D. pp. 283-308. New York: Raven Press.
19. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br. J. Pharmacol., 115, 1064-1070.
20. 1A Receptors in Depression and Anxiety. ed. Stahl, S.M., Gastpar, M., Keppel Hesselink, J.M. & Traber, J. pp. 35-53. New York: Raven Press.
21. 3H]dopa in various regions of the brain. J. Neurochem., 13, 655-669.
22. 1A receptor binding sites in rat brain membranes. Eur. J. Pharmacol. - Mol. Pharmacol. Sect., 288, 173-186.
23. 1A receptor antagonists NAN-190 and BMY7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur. J. Pharmacol., 211, 211-219.
24. 1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study. Neuroscience, 41, 495-505.
25. 1B receptor binding sites in brain? Trends Pharmacol. Sci., 7, 336-338.
26. 1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI). Behav. Brain Res., 73, 281-283.
27. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J. Pharmacol. Exp. Ther., 268, 1432-1443.
28. KENAKIN, T. (1993). Pharmacologic Analysis of Drug-Receptor Interaction. New York: Raven Press.
29. 1A receptors in the rat central nervous system. J. Comp. Neurol., 365, 289-305.
30. 1B receptors. Eur. J. Pharmacol. - Mol. Pharmacol. Sect., 244, 77-87.
31. 3H]WAY 100635 in the mouse. Eur. J. Pharmacol., 271, 505-514.
32. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 141-148.
33. LEFF, P. & DOUGALL, I.G. (1993). Further concerns over Cheng-Prusoff analysis. Trends Pharmacol. Sci., 14, 110-112.
34. LEVY, A.D., LI, Q., GUSTAFSON, M. & VAN DE KAR, L.D. (1995). Neuroendocrine profile of the potential anxiolytic drug S-20499. Eur. J. Pharmacol., 274, 141-149.
35. MONTGOMERY, S.A. (1995). Selective serotonin reuptake inhibitors in the acute treatment of depression. In: Psychopharmacology: the Fourth Generation of Progress. ed. Bloom, F.E. & Kupfer, D.J. pp. 1043-1051. New York: Raven Press.
36. MONTI, J.M. & JANTOS, H. (1994). Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness. Neuropharmacology, 33, 705-708.
37. NEWBERRY, N.R. & NICOLL, R.A. (1985). Comparison of the action of baclofen with gamma-aminobutyric acid on rat hippocampal pyramidal cells in vitro. J. Physiol., 360, 161-185.
38. RANG, H.P. (1966). The kinetics of acetylcholine antagonists in smooth muscle. Proc. R. Soc. Lond. (Biology). 164, 488-510.
39. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology, 15, 349-360.
40. 1A agonists. J. Pharmacol. Exp. Ther., 270, 198-208.
41. SNEDECOR, G.W. & COCHRAN, W.G. (1967). Statistical Methods. Ames: Iowa State College Press.
42. 1B agonists. Synapse. 1, 3-9.
43. VANDERMAELEN, C.P. & AGHAJANIAN, G.K. (1983). Electrophysiological and pharmacological characterization of serotoninergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res., 289, 109-119.
44. 1A antagonists and PCPA. Pharmacol. Biochem. Behav., 47, 957-962.
45. 1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Mol. Pharmacol., 41, 1066-1072.